Author:
Bahner Nicole,Reich Peggy,Frense Dieter,Menger Marcus,Schieke Katharina,Beckmann Dieter
Funder
Bundesministerium für Wirtschaft und Energie
Publisher
Springer Science and Business Media LLC
Subject
Biochemistry,Analytical Chemistry
Reference48 articles.
1. Rahman A, Goodman A, Foo W, Harvey J, Smith FP, Schein PS. Clinical pharmacology of daunorubicin in Phase I patients with solid tumors: development of an analytical methodology for daunorubicin and its metabolites. Semin Oncol. 1984;11(4):36–44.
2. de los Santos-Alvarez N, Lobo-Castanon MJ, Miranda-Ordieres AJ, Tunon-Blanco P (2008) Aptamers as recognition elements for label-free analytical devices. TrAC Trends Anal Chem 27(5):437-446
3. Hanna AD, Lam A, Tham S, Dulhunty AF, Beard NA. Adverse effects of doxorubicin and its metabolic product on cardiac RyR2 and SERCA2A. Mol Pharmacol. 2014;86(4):438–49.
4. Mahnik SN, Lenz K, Weissenbacher N, Mader RM, Fuerhacker M. Fate of 5-fluorouracil, doxorubicin, epirubicin, and daunorubicin in hospital wastewater and their elimination by activated sludge and treatment in a membrane-bio-reactor system. Chemosphere. 2007;66, 30(1):–37.
5. Chisvert A, Sisternes J, Balaguer Á, Salvador A. A gas chromatography–mass spectrometric method to determine skin-whitening agents in cosmetic products. Talanta. 2010;81(1):530–6.
Cited by
56 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献